Cholinergic neuron-specific ganglioside GQ1b alpha a possible target molecule for serum IgM antibodies in some patients with sensory ataxia.
In neurological diseases the presence of certain anti-glycosphingolipid antibody species is associated with the clinical features. We recently isolated the novel cholinergic neuron-specific gangliosides GQ1b alpha and GT1a alpha from bovine brain. A monoclonal antibody specific for GQ1b alpha and GT1a alpha reacted strongly with the dorsal born of human spinal cord but not with human motor neurons. We investigated the serum antibodies to these minor gangliosides in a number of neurologic diseases and found that 4 patients with sensory ataxic neuropathy had a remarkably high IgM anti-GQ1b alpha antibody titer. GQ1b alpha may be a target molecule for serum IgM antibodies in some patients with sensory ataxic neuropathy.
Tagawa
Y
Y
Department of Biochemistry, Faculty of Medicine, Tokyo Medical and Dental University, Japan.
Irie
F
F
Hirabayashi
Y
Y
Yuki
N
N
D000818:Animals; D000906:Antibodies / Q000032:analysis / Q000276:immunology*; D001259:Ataxia / Q000276:immunology*; D002417:Cattle; D005732:Gangliosides / Q000276:immunology* / Q000378:metabolism; D006801:Humans; D007075:Immunoglobulin M / Q000276:immunology*; D009474:Neurons / Q000378:metabolism; D010275:Parasympathetic Nervous System / Q000166:cytology / Q000378:metabolism*; D012678:Sensation Disorders / Q000276:immunology*
D000906:Antibodies; D005732:Gangliosides; D007075:Immunoglobulin M; C039129:GQ1b ganglioside